Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1986 2
1987 3
1988 4
1989 9
1990 6
1991 5
1992 3
1993 2
1994 5
1995 2
1996 3
1997 3
1998 3
1999 2
2000 2
2001 2
2002 3
2003 2
2004 3
2005 5
2006 4
2007 1
2008 3
2009 7
2010 6
2011 11
2012 8
2013 11
2014 15
2015 20
2016 22
2017 17
2018 6
2019 15
2020 10
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

206 results
Results by year
Filters applied: . Clear all
Page 1
Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction.
Schimmel K, Jung M, Foinquinos A, José GS, Beaumont J, Bock K, Grote-Levi L, Xiao K, Bär C, Pfanne A, Just A, Zimmer K, Ngoy S, López B, Ravassa S, Samolovac S, Janssen-Peters H, Remke J, Scherf K, Dangwal S, Piccoli MT, Kleemiss F, Kreutzer FP, Kenneweg F, Leonardy J, Hobuß L, Santer L, Do QT, Geffers R, Braesen JH, Schmitz J, Brandenberger C, Müller DN, Wilck N, Kaever V, Bähre H, Batkai S, Fiedler J, Alexander KM, Wertheim BM, Fisch S, Liao R, Diez J, González A, Thum T. Schimmel K, et al. Among authors: kaever v. Circulation. 2020 Mar 3;141(9):751-767. doi: 10.1161/CIRCULATIONAHA.119.042559. Epub 2020 Jan 17. Circulation. 2020. PMID: 31948273 Free PMC article.
[Principles of immunosuppression].
Kaever V, Resch K. Kaever V, et al. Pharm Unserer Zeit. 2005;34(4):268-75. doi: 10.1002/pauz.200500126. Pharm Unserer Zeit. 2005. PMID: 16041954 Review. German. No abstract available.
cUMP hydrolysis by PDE3B.
Ostermeyer J, Golly F, Kaever V, Dove S, Seifert R, Schneider EH. Ostermeyer J, et al. Among authors: kaever v. Naunyn Schmiedebergs Arch Pharmacol. 2018 Sep;391(9):891-905. doi: 10.1007/s00210-018-1512-6. Epub 2018 May 28. Naunyn Schmiedebergs Arch Pharmacol. 2018. PMID: 29808231
cUMP hydrolysis by PDE3A.
Berrisch S, Ostermeyer J, Kaever V, Kälble S, Hilfiker-Kleiner D, Seifert R, Schneider EH. Berrisch S, et al. Among authors: kaever v. Naunyn Schmiedebergs Arch Pharmacol. 2017 Mar;390(3):269-280. doi: 10.1007/s00210-016-1328-1. Epub 2016 Dec 14. Naunyn Schmiedebergs Arch Pharmacol. 2017. PMID: 27975297
Fucosylated lipid nanocarriers loaded with antibiotics efficiently inhibit mycobacterial propagation in human myeloid cells.
Durán V, Grabski E, Hozsa C, Becker J, Yasar H, Monteiro JT, Costa B, Koller N, Lueder Y, Wiegmann B, Brandes G, Kaever V, Lehr CM, Lepenies B, Tampé R, Förster R, Bošnjak B, Furch M, Graalmann T, Kalinke U. Durán V, et al. Among authors: kaever v. J Control Release. 2021 Jun 10;334:201-212. doi: 10.1016/j.jconrel.2021.04.012. Epub 2021 Apr 16. J Control Release. 2021. PMID: 33865899 Free article.
cCMP is a substrate for MRP5.
Laue S, Winterhoff M, Kaever V, van den Heuvel JJ, Russel FG, Seifert R. Laue S, et al. Among authors: kaever v. Naunyn Schmiedebergs Arch Pharmacol. 2014 Sep;387(9):893-5. doi: 10.1007/s00210-014-1018-9. Epub 2014 Jul 15. Naunyn Schmiedebergs Arch Pharmacol. 2014. PMID: 25017019
Dinucleotide Degradation by REXO2 Maintains Promoter Specificity in Mammalian Mitochondria.
Nicholls TJ, Spåhr H, Jiang S, Siira SJ, Koolmeister C, Sharma S, Kauppila JHK, Jiang M, Kaever V, Rackham O, Chabes A, Falkenberg M, Filipovska A, Larsson NG, Gustafsson CM. Nicholls TJ, et al. Among authors: kaever v. Mol Cell. 2019 Dec 5;76(5):784-796.e6. doi: 10.1016/j.molcel.2019.09.010. Epub 2019 Oct 3. Mol Cell. 2019. PMID: 31588022 Free PMC article.
cCMP and cUMP occur in vivo.
Bähre H, Hartwig C, Munder A, Wolter S, Stelzer T, Schirmer B, Beckert U, Frank DW, Tümmler B, Kaever V, Seifert R. Bähre H, et al. Among authors: kaever v. Biochem Biophys Res Commun. 2015 May 15;460(4):909-14. doi: 10.1016/j.bbrc.2015.03.115. Epub 2015 Mar 31. Biochem Biophys Res Commun. 2015. PMID: 25838203 Free PMC article.
206 results